NEUROG2 encodes neurogenin-2, a proneural basic helix-loop-helix (bHLH) transcription factor that is the predominant neurogenin in mammalian cortical neurogenesis. The protein functions in the nucleus where it binds E-box DNA motifs (CANNTG), with preference for CAT-containing E-boxes, forming heterodimers with E-proteins to activate transcription. NEUROG2 drives neuronal fate commitment and differentiation by directly activating key neurogenic target genes including Dll1, Dll3, Rnd2, Neurod1, Neurod2, and Lhx2. The protein exhibits context-dependent chromatin binding and pioneer-like activity that is modulated by phosphorylation at T149, which acts as a rheostat between chromatin remodeling and transactivation functions. In cortical progenitors, NEUROG2 is enriched in intermediate progenitors where it initiates neuronal differentiation programs. Its activity is suppressed by LHX2 in progenitors to regulate proper dendritic morphogenesis. NEUROG2 displays human-specific regulatory programs including activation of PPP1R17 and ECM genes. It is also upregulated in MYCN-driven neuroendocrine prostate cancer where it becomes essential for maintaining neuroendocrine differentiation.
Definition: The process in which a relatively unspecialized cell acquires specialized features of a glutamatergic neuron, an excitatory neuron that uses glutamate as its primary neurotransmitter.
Justification: NEUROG2 is known to specify excitatory glutamatergic neuron fate in cortex, but this specific function is not captured in existing annotations. A more specific term than general neuron differentiation would capture this cell type-specific function.
Supporting Evidence:
Definition: Any process that stops, prevents, or reduces the frequency, rate or extent of glial cell differentiation.
Justification: Proneural factors like NEUROG2 promote neuronal fate while suppressing glial fate in neural progenitors. This reciprocal regulation is an important aspect of NEUROG2 function not represented in current annotations.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific | IBA GO_REF:0000033 | ACCEPT | Summary: Core molecular function annotation for NEUROG2 as a bHLH transcription factor that activates RNA Pol II-dependent transcription Reason: This annotation correctly captures NEUROG2's primary molecular function as a sequence-specific transcription factor that drives RNA polymerase II-mediated transcription. Deep research confirms NEUROG2 binds E-box motifs and activates neurogenic gene expression programs including Dll1, Dll3, Rnd2, Neurod1, Neurod2, and Lhx2. IBA evidence is supported by extensive experimental data showing direct transcriptional activation activity. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 is a proneural bHLH transcription factor that activates neuronal differentiation programs in the developing cortex. Context-dependent binding of NEUROG2, with direct activation of canonical targets Dll1/Dll3, Rnd2, Neurod1/2, and Lhx2, has been demonstrated. |
| GO:0005634 nucleus | IBA GO_REF:0000033 | ACCEPT | Summary: Core localization annotation for NEUROG2 nuclear function Reason: NEUROG2 functions as a nuclear transcription factor, consistent with its role in binding DNA and activating transcription. Deep research confirms nuclear localization as the site where NEUROG2 regulates gene expression and exhibits chromatin remodeling activity. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md As a transcription factor, NEUROG2 functions in the nucleus to regulate gene expression. In human cortical progenitors, phosphorylation at T149 modulates a pioneer-like mode that increases chromatin accessibility. |
| GO:0007423 sensory organ development | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: Annotation reflects phylogenetically conserved neurogenin function in sensory neurogenesis but peripheral to NEUROG2 human core function Reason: While neurogenins including NEUROG2 have conserved roles in sensory organ development across vertebrates (particularly in sensory ganglia), the human deep research focuses primarily on cortical neurogenesis. This annotation is based on IBA phylogenetic inference and represents a non-core function for human NEUROG2, which is predominantly expressed in cortical progenitors rather than sensory organs. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 is widely recognized as the predominant neurogenin in corticogenesis. In human fetal cortex datasets and human cerebral organoids, NEUROG2 is broadly expressed in neural progenitors, particularly IPCs. |
| GO:0030900 forebrain development | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: Annotation for forebrain development represents one developmental context for NEUROG2 function but not the specific core process Reason: Forebrain development is one anatomical context where NEUROG2 functions during cortical neurogenesis. However, this annotation is too general and represents a developmental context rather than the core process of neuronal differentiation and fate commitment that NEUROG2 directly mediates. The more specific processes of neuron differentiation and neurogenesis better capture NEUROG2's core function. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 enrichment in human cortical progenitors, especially intermediate progenitors (IPCs), and identifies a human-specific NEUROG2 program. |
| GO:0070888 E-box binding | IBA GO_REF:0000033 | ACCEPT | Summary: Core molecular function annotation for NEUROG2's specific DNA binding activity Reason: E-box binding (CANNTG motifs) is the fundamental DNA recognition mechanism by which NEUROG2 executes its transcription factor activity. Deep research extensively documents NEUROG2's preference for CAT-containing E-boxes and direct binding to target gene promoters/enhancers. This is more specific and informative than generic DNA binding. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 binds E-box (CANNTG) motifs. Human fibroblast reprogramming data report a preference toward CAT E-box variants for NGN2 relative to ASCL1's CAG preference, corresponding to differential target selection during early conversion. |
| GO:0045944 positive regulation of transcription by RNA polymerase II | IBA GO_REF:0000033 | ACCEPT | Summary: Core biological process annotation for NEUROG2's transcriptional activation function Reason: NEUROG2 positively regulates transcription of its target genes via RNA polymerase II, activating neurogenic programs. This annotation accurately captures the regulatory directionality and mechanism of NEUROG2's function, consistent with experimental evidence showing upregulation of Dll1, Dll3, Rnd2, Neurod1, Neurod2, and other targets. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md Direct activation of proneural targets including Dll1, Rnd2, Lhx2, Neurod1/2. Single-factor NGN2 (NEUROG2) ectopic expression in human LF1 fibroblasts produced the strongest pro-neural transcriptional reconfiguration. |
| GO:0061564 axon development | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: Annotation reflects downstream consequence of NEUROG2-driven neuronal differentiation rather than core function Reason: Axon development is a cellular morphogenetic process that occurs downstream of neuronal fate specification and differentiation. While NEUROG2-expressing neurons subsequently develop axons, and NEUROG2 targets like Rnd2 affect neurite outgrowth, axon development is not the core function of NEUROG2 itself, which is neuronal fate commitment and differentiation at the progenitor stage. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md In human fetal cortex datasets and human cerebral organoids, NEUROG2 is broadly expressed in neural progenitors, particularly IPCs, and is scarce in postmitotic neurons, indicating a progenitor-focused role in fate commitment and program initiation. |
| GO:0003677 DNA binding | IEA GO_REF:0000043 | MODIFY | Summary: Generic DNA binding annotation is too broad; E-box binding is more specific and informative Reason: While NEUROG2 does bind DNA, this annotation is too generic and uninformative. The more specific GO:0070888 (E-box binding) better captures the actual molecular function. DNA binding alone doesn't distinguish NEUROG2 from hundreds of other DNA-binding proteins. Should be replaced with the more specific E-box binding annotation already present. Proposed replacements: E-box binding Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 binds E-box (CANNTG) motifs with preference for CAT E-box variants. |
| GO:0005634 nucleus | IEA GO_REF:0000044 | ACCEPT | Summary: Duplicate annotation of nuclear localization with IEA evidence Reason: This is a duplicate of the IBA annotation for nucleus (GO:0005634). Both annotations are correct. The IEA evidence from UniProt subcellular location mapping complements the IBA phylogenetic evidence. Duplicate annotations with different evidence codes are acceptable in GO. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md As a transcription factor, NEUROG2 functions in the nucleus to regulate gene expression. |
| GO:0007399 nervous system development | IEA GO_REF:0000043 | MODIFY | Summary: Very broad developmental process annotation that lacks specificity Reason: While NEUROG2 does function in nervous system development, this annotation is too general. More specific terms like neuron differentiation, neurogenesis, or neuron fate commitment better capture NEUROG2's specific role in generating neurons from progenitors. Nervous system development encompasses many processes beyond neurogenesis where NEUROG2 is not directly involved. Proposed replacements: neuron differentiation neurogenesis Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 is a proneural bHLH transcription factor that activates neuronal differentiation programs. NEUROG2 is widely recognized as the predominant neurogenin in corticogenesis and a central regulator of neurogenic fate. |
| GO:0030154 cell differentiation | IEA GO_REF:0000043 | MODIFY | Summary: Overly generic cell differentiation annotation that should be replaced with neuron-specific differentiation Reason: This annotation is too generic. NEUROG2 specifically drives neuronal differentiation, not general cell differentiation. The term GO:0030182 (neuron differentiation) is far more specific and informative. Cell differentiation applies to thousands of genes across all cell types and provides little functional insight into NEUROG2's specific role. Proposed replacements: neuron differentiation Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 activates neuronal differentiation programs. Involved in neuronal differentiation. Activates transcription by binding to the E box. |
| GO:0046983 protein dimerization activity | IEA GO_REF:0000002 | ACCEPT | Summary: Annotation for bHLH dimerization activity essential for DNA binding function Reason: Protein dimerization is a fundamental aspect of bHLH transcription factor function. NEUROG2 must form heterodimers with E-proteins to bind DNA effectively. This annotation is mechanistically important for understanding how NEUROG2 achieves its DNA binding activity, though it is a supporting function rather than the primary activity. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-uniprot.txt Efficient DNA binding requires dimerization with another bHLH protein. file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 acts as a bHLH dimer; context-dependent cooperation with other TFs and chromatin regulators is prominent. |
| GO:1990837 sequence-specific double-stranded DNA binding | IEA GO_REF:0000117 | ACCEPT | Summary: Accurate molecular function annotation for sequence-specific DNA binding Reason: This annotation correctly captures NEUROG2's ability to bind DNA in a sequence-specific manner (E-box motifs). The sequence-specificity is critical for target gene selectivity. This complements the E-box binding annotation by emphasizing the sequence-dependent nature of the interaction with double-stranded DNA. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 binds E-box (CANNTG) motifs. Human fibroblast reprogramming data report a preference toward CAT E-box variants. |
| GO:0005515 protein binding | IPI PMID:32296183 A reference map of the human binary protein interactome | REMOVE | Summary: Generic protein binding annotation lacks functional specificity Reason: Per curation guidelines, protein binding is uninformative and should be avoided unless no better term exists. This annotation from a high-throughput Y2H screen (HuRI) identifies PFDN5 (Q99471) as an interactor but provides no functional insight. The specific interactor may be biologically relevant, but the generic protein binding term should be removed. More specific molecular function terms like protein dimerization activity or transcription coregulator binding would be more informative if the functional significance of this interaction were established. Supporting Evidence: PMID:32296183 Apr 8. A reference map of the human binary protein interactome. |
| GO:1990837 sequence-specific double-stranded DNA binding | IDA PMID:28473536 Impact of cytosine methylation on DNA binding specificities ... | ACCEPT | Summary: Experimental evidence for sequence-specific DNA binding from systematic TF binding study Reason: This annotation is supported by direct experimental evidence from a systematic study of human transcription factor DNA binding specificities using HT-SELEX. The IDA evidence provides strong experimental support for NEUROG2's sequence-specific DNA binding activity. This is a duplicate of the IEA annotation above but with stronger experimental evidence. Supporting Evidence: PMID:28473536 By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution of ligands by exponential enrichment), we found that there are also many TFs that prefer CpG-methylated sequences |
| GO:0000785 chromatin | ISA GO_REF:0000113 | ACCEPT | Summary: Annotation for chromatin localization reflects pioneer-like chromatin remodeling activity Reason: NEUROG2 exhibits pioneer-like transcription factor activity, directly engaging chromatin and promoting chromatin accessibility. Deep research shows that NEUROG2 phosphorylation at T149 modulates pioneer-like chromatin remodeling capacity. Chromatin localization is more specific than general nuclear localization and reflects NEUROG2's ability to bind and remodel chromatin structure. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 displays context-dependent genomic occupancy and can associate with chromatin opening. In human cortical progenitors, phosphorylation at T149 modulates a pioneer-like mode that increases chromatin accessibility. A T149A mutant increased neurogenesis and premature chromatin opening. |
| GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific | ISA GO_REF:0000113 | ACCEPT | Summary: Duplicate core molecular function annotation with ISA evidence from TFClass Reason: This is a duplicate of the IBA annotation for the same term. The ISA evidence comes from manual assignment based on TFClass database classification of NEUROG2 as a bHLH transcription factor. Multiple lines of evidence for the same annotation strengthen confidence. Duplicate annotations with different evidence types are acceptable. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 is a sequence-specific bHLH transcription factor that initiates and propagates neurogenic gene expression programs. |
| GO:0070888 E-box binding | ISS GO_REF:0000024 | ACCEPT | Summary: Duplicate core molecular function annotation with ISS evidence from ortholog Reason: This is a duplicate of the IBA annotation for E-box binding. The ISS evidence indicates manual transfer from mouse ortholog (UniProtKB:P70447), which has experimental evidence for E-box binding. This complements the IBA phylogenetic evidence. Multiple evidence codes strengthen the annotation. Supporting Evidence: file:genes/human/NEUROG2/NEUROG2-deep-research-falcon.md NEUROG2 binds E-box (CANNTG) motifs with demonstrated preference for CAT E-box variants. |
Loading supporting content…
Download this section (compressed HTML)Q: What is the functional significance of the NEUROG2-PFDN5 interaction identified in the HuRI interactome?
Q: Are there specific E-protein partners (e.g., TCF3, TCF4, TCF12) that preferentially heterodimerize with NEUROG2 in cortical progenitors?
Q: How do the human-specific NEUROG2 targets (PPP1R17, ECM genes) contribute to human cortical expansion?
Q: What is the mechanism by which LHX2 suppresses NEUROG2 expression in progenitors?
Q: Does NEUROG2 regulate astrocyte versus neuron fate decisions, and if so, through what molecular mechanism?
Q: What are the specific glutamatergic neuron subtypes generated by NEUROG2 in different cortical layers?
Experiment: ChIP-seq in human cortical organoids to identify direct NEUROG2 genomic targets in human progenitors
Experiment: Single-cell RNA-seq time course of NEUROG2+ progenitors through differentiation to define the complete NEUROG2-driven transcriptional cascade
Experiment: CRISPR screen in NEUROG2-expressing progenitors to identify cofactors and modulators of NEUROG2 activity
Experiment: Biochemical purification and mass spectrometry to identify NEUROG2 protein complexes and E-protein partners in cortical tissue
Experiment: Functional analysis of T149 phosphorylation site mutants to dissect pioneer activity versus transactivation functions
Experiment: CUT&RUN or CUT&Tag to map NEUROG2 chromatin binding at high resolution
Experiment: Lineage tracing experiments to definitively map the neuronal subtypes produced by NEUROG2+ progenitors
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)